Nina Wagner-Johnston

Associate Professor

19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial

Wagner-Johnston, N. D., Sloan, J. A., Liu, H., Kearns, A. E., Hines, S. L., Puttabasavaiah, S., Dakhil, S. R., Lafky, J. M., Perez, E. A. & Loprinzi, C. L., Aug 1 2015, In : Cancer. 121, 15, p. 2537-2543 7 p.

Research output: Contribution to journalArticle

AMC 048: Modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma

AIDS Malignancy Consortium, Jul 9 2015, In : Blood. 126, 2, p. 160-166 7 p.

Research output: Contribution to journalArticle

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

Garzon, R., Savona, M., Baz, R., Andreeff, M., Gabrail, N., Gutierrez, M., Savoie, L., Mau-Sorensen, P. M., Wagner-Johnston, N., Yee, K., Unger, T. J., Saint-Martin, J. R., Carlson, R., Rashal, T., Kashyap, T., Klebanov, B., Shacham, S., Kauffman, M. & Stone, R., Jun 15 2017, In : Blood. 129, 24, p. 3165-3174 10 p.

Research output: Contribution to journalArticle

A phase 1 study of the PI3Kd inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)

Kahl, B. S., Spurgeon, S. E., Furman, R. R., Flinn, I. W., Coutre, S. E., Brown, J. R., Benson, D. M., Byrd, J. C., Peterman, S., Cho, Y., Yu, A., Godfrey, W. R. & Wagner-Johnston, N. D., May 29 2014, In : Blood. 123, 22, p. 3398-3405 8 p.

Research output: Contribution to journalArticle

A phase 2/3 multicenter, randomized, open-label study to compare the efficacy and safety of lenalidomide versus investigator's choice in patients with relapsed or refractory diffuse large B-cell lymphoma

Czuczman, M. S., Trněný, M., Davies, A., Rule, S., Linton, K. M., Wagner-Johnston, N., Gascoyne, R. D., Slack, G. W., Brousset, P., Eberhard, D. A., Hernandez-Ilizaliturri, F. J., Salles, G., Witzig, T. E., Zinzani, P. L., Wright, G. W., Staudt, L. M., Yang, Y., Williams, P. M., Lih, C. J., Russo, J. & 5 others, Thakurta, A., Hagner, P., Fustier, P., Song, D. & Lewis, I. D., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4127-4137 11 p.

Research output: Contribution to journalArticle

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

Fehniger, T. A., Larson, S., Trinkaus, K., Siegel, M. J., Cashen, A. F., Blum, K. A., Fenske, T. S., Hurd, D. D., Goy, A., Schneider, S. E., Keppel, C. R., Wagner-Johnston, N. D., Carson, K. R. & Bartlett, N. L., Nov 10 2011, In : Blood. 118, 19, p. 5119-5125 7 p.

Research output: Contribution to journalArticle

A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma

Wagner-Johnston, N. D., Goy, A., Rodriguez, M. A., Ehmann, W. C., Hamlin, P. A., Radford, J., Thieblemont, C., Suh, C., Sweetenham, J., Huang, Y., Sullivan, S. T., Vandendries, E. R. & Gisselbrecht, C., Oct 3 2015, In : Leukemia and Lymphoma. 56, 10, p. 2863-2869 7 p.

Research output: Contribution to journalArticle

A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy

Goy, A., Forero, A., Wagner-Johnston, N., Christopher Ehmann, W., Tsai, M., Hatake, K., Ananthakrishnan, R., Volkert, A., Vandendries, E. & Ogura, M., Aug 1 2016, In : British Journal of Haematology. 174, 4, p. 571-581 11 p.

Research output: Contribution to journalArticle

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

Maly, J. J., Christian, B. A., Zhu, X., Wei, L., Sexton, J. L., Jaglowski, S. M., Devine, S. M., Fehniger, T. A., Wagner-Johnston, N., Phelps, M. A., Bartlett, N. L. & Blum, K. A., Jun 1 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 6, p. 347-353 7 p.

Research output: Contribution to journalArticle

CALGB 50604: Risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET

Straus, D. J., Jung, S. H., Pitcher, B., Kostakoglu, L., Grecula, J. C., Hsi, E. D., Schöder, H., Popplewell, L. L., Chang, J. E., Moskowitz, C. H., Wagner-Johnston, N., Leonard, J. P., Friedberg, J. W., Kahl, B. S., Cheson, B. D. & Bartlett, N. L., Sep 6 2018, In : Blood. 132, 10, p. 1013-1021 9 p.

Research output: Contribution to journalArticle

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 others, Mato, A., Mosse, C., Neppalli, V. T., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N., Dwyer, M. A. & Sundar, H., Jan 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.

Research output: Contribution to journalArticle

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Lim, M. S., Ma, S. & 10 others, Malek, S., Mato, A., Mosse, C., Shadman, M., Siddiqi, T., Stephens, D., Sundaram, S., Wagner, N., Dwyer, M. & Sundar, H., Feb 1 2020, In : Journal of the National Comprehensive Cancer Network : JNCCN. 18, 2, p. 185-217 33 p.

Research output: Contribution to journalArticle

Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (Alliance)

Pachman, D. R., Qin, R., Seisler, D. K., Smith, E. M. L., Beutler, A. S., Ta, L. E., Lafky, J. M., Wagner-Johnston, N. D., Ruddy, K. J., Dakhil, S., Staff, N. P., Grothey, A. & Loprinzi, C. L., Oct 20 2015, In : Journal of Clinical Oncology. 33, 30, p. 3416-3422 7 p.

Research output: Contribution to journalArticle

Clonal immunoglobulin DNA in the plasma of patients with AIDS lymphoma

Wagner-Johnston, N. D., Gellert, L., Gocke, C. D., Lemas, V. M., Lee, J., Martínez-Maza, O. & Ambinder, R. F., May 5 2011, In : Blood. 117, 18, p. 4860-4862 3 p.

Research output: Contribution to journalArticle

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma

Carson, K. R., Riedell, P., Lynch, R., Nabhan, C., Wildes, T. M., Liu, W., Ganti, A., Roop, R., Sanfilippo, K. M., O'Brian, K., Liu, J., Bartlett, N. L., Cashen, A., Wagner-Johnston, N., Fehniger, T. A. & Colditz, G. A., May 1 2015, In : Journal of Geriatric Oncology. 6, 3, p. 211-218 8 p.

Research output: Contribution to journalArticle

Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505)

Pachman, D. R., Qin, R., Seisler, D., Smith, E. M. L., Kaggal, S., Novotny, P., Ruddy, K. J., Lafky, J. M., Ta, L. E., Beutler, A. S., Wagner-Johnston, N., Staff, N. P., Grothey, A., Dougherty, P. M., Cavaletti, G. & Loprinzi, C. L., Aug 18 2016, (Accepted/In press) In : Supportive Care in Cancer. p. 1-10 10 p.

Research output: Contribution to journalArticle

Computer/online-mediated social support for cancer-related fatigue

Wagner-Johnston, N., Oct 1 2013, In : JNCCN Journal of the National Comprehensive Cancer Network. 11, 10, p. 1211-1217 7 p.

Research output: Contribution to journalArticle

De novo large B-cell lymphoma in a parenchymal brain lesion: Evidence of clonal evolution from splenic marginal zone lymphoma

Fadugba, O., Nguyen, T. D. T., McGill, J. & Wagner-Johnston, N., Mar 20 2011, In : Journal of Clinical Oncology. 29, 9, p. e234-e236

Research output: Contribution to journalArticle

Diffusion-weighted MRI for staging and evaluation of response in diffuse large B-cell lymphoma: A pilot study

Siegel, M. J., Jokerst, C. E., Rajderkar, D., Hildebolt, C. F., Goyal, S., Dehdashti, F., Wagner Johnston, N. & Siegel, B. A., Jun 2014, In : NMR in biomedicine. 27, 6, p. 681-691 11 p.

Research output: Contribution to journalArticle

Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the Phase III intergroup trial alliance/CALGB 50303

Bartlett, N. L., Wilson, W. H., Jung, S. H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M. Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., Friedberg, J. W., Staudt, L. M., Wagner-Johnston, N. D., Blum, K. A., Abramson, J. S., Reddy, N. M., Winter, J. N., Chang, J. E., Gopal, A. K., Chadburn, A. & 6 others, Mathew, S., Fisher, R. I., Richards, K. L., Schoder, H., Zelenetz, A. D. & Leonard, J. P., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1790-1799 10 p.

Research output: Contribution to journalArticle

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854

Bartlett, N. L., Petroni, G. R., Parker, B. A., Wagner, N. D., Gockerman, J. P., Omura, G. A., Canellos, G. P., Robertcooper, M., Johnson, J. L. & Peterson, B. A., Jul 15 2001, In : Cancer. 92, 2, p. 207-217 11 p.

Research output: Contribution to journalArticle

DYNAMO: A Phase II study of duvelisib (IPI-145) in patients with refractory indolent non-hodgkin lymphoma

Flinn, I. W., Miller, C. B., Ardeshna, K. M., Tetreault, S., Assouline, S. E., Mayer, J., Merli, M., Lunin, S. D., Pettitt, A. R., Nagy, Z., Tournilhac, O., Abou-Nassar, K. E., Crump, M., Jacobsen, E. D., De Vos, S., Kelly, V. M., Shi, W., Steelman, L., Le, N. D., Weaver, D. T. & 3 others, Lustgarten, S., Wagner-Johnston, N. D. & Zinzani, P. L., Jan 1 2019, In : Journal of Clinical Oncology. 37, 11, p. 912-922 11 p.

Research output: Contribution to journalArticle

Open Access

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial

Jones, J. A., Robak, T., Brown, J. R., Awan, F. T., Badoux, X., Coutre, S., Loscertales, J., Taylor, K., Vandenberghe, E., Wach, M., Wagner-Johnston, N., Ysebaert, L., Dreiling, L., Dubowy, R., Xing, G., Flinn, I. W. & Owen, C., Mar 1 2017, In : The Lancet Haematology. 4, 3, p. e114-e126

Research output: Contribution to journalArticle

First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL

Byrd, J. C., Smith, S., Wagner-Johnston, N., Sharman, J., Chen, A. I., Advani, R., Augustson, B., Marlton, P., Commerford, S. R., Okrah, K., Liu, L., Murray, E., Penuel, E., Ward, A. F. & Flinn, I. W., Jan 1 2018, In : Oncotarget. 9, 16, p. 13023-13035 13 p.

Research output: Contribution to journalArticle

Open Access

High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064)

Wagner-Johnston, N., Lensing, S., Noy, A., Ratner, L., Henry, D., Lee, J. Y., Silver, S., Faham, M. & Ambinder, R. F., May 15 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-4 4 p.

Research output: Contribution to journalArticle

High incidence of methotrexate associated renal toxicity in patients with lymphoma: A retrospective analysis

May, J., Carson, K. R., Butler, S., Liu, W., Bartlett, N. L. & Wagner-Johnston, N. D., Jun 2014, In : Leukemia and Lymphoma. 55, 6, p. 1345-1349 5 p.

Research output: Contribution to journalArticle

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

Brown, J. R., Byrd, J. C., Coutre, S. E., Benson, D. M., Flinn, I. W., Wagner-Johnston, N. D., Spurgeon, S. E., Kahl, B. S., Bello, C., Webb, H. K., Johnson, D. M., Peterman, S., Li, D., Jahn, T. M., Lannutti, B. J., Ulrich, R. G., Yu, A. S., Miller, L. L. & Furman, R. R., May 29 2014, In : Blood. 123, 22, p. 3390-3397 8 p.

Research output: Contribution to journalArticle

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma

Flinn, I. W., Kahl, B. S., Leonard, J. P., Furman, R. R., Brown, J. R., Byrd, J. C., Wagner-Johnston, N. D., Coutre, S. E., Benson, D. M., Peterman, S., Cho, Y., Webb, H. K., Johnson, D. M., Yu, A. S., Ulrich, R. G., Godfrey, W. R., Miller, L. L. & Spurgeon, S. E., May 29 2014, In : Blood. 123, 22, p. 3406-3413 8 p.

Research output: Contribution to journalArticle

IgH gene rearrangements as plasma biomarkers in non-Hodgkin's Lymphoma patients

He, J., Wu, J., Jiao, Y., Wagner-Johnston, N., Ambinder, R. F., Diaz, L. A., Kinzler, K. W., Vogelstein, B. & Papadopoulos, N., 2011, In : Oncotarget. 2, 3, p. 178-185 8 p.

Research output: Contribution to journalArticle

Open Access

Implication of Rituximab Infusion Reactions on Clinical Outcomes in Patients With Diffuse Large B-cell Lymphoma: A Single Institution Experience

Patel, D. A., Johanns, T. M., Trinkaus, K., Bartlett, N. L., Wagner-Johnston, N. & Cashen, A. F., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission

Pingali, S. R., Jewell, S. W., Havlat, L., Bast, M. A., Thompson, J. R., Eastwood, D. C., Bartlett, N. L., Armitage, J. O., Wagner-Johnston, N. D., Vose, J. M. & Fenske, T. S., Jan 1 2014, In : Cancer. 120, 14, p. 2122-2129 8 p.

Research output: Contribution to journalArticle

MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

Zimmerman, C., Atherton, P. J., Pachman, D., Seisler, D., Wagner-Johnston, N., Dakhil, S., Lafky, J. M., Qin, R., Grothey, A. & Loprinzi, C. L., Mar 1 2016, In : Supportive Care in Cancer. 24, 3, p. 1071-1078 8 p.

Research output: Contribution to journalArticle

Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study

Goyal, S., Oak, E., Luo, J., Cashen, A. F., Carson, K., Fehniger, T., DiPersio, J., Bartlett, N. L. & Wagner-Johnston, N. D., Jun 9 2017, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-6 6 p.

Research output: Contribution to journalArticle

Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure

Ayers, E. C., Li, S., Medeiros, L. J., Bond, D. A., Maddocks, K. J., Torka, P., Mier Hicks, A., Curry, M., Wagner-Johnston, N. D., Karmali, R., Behdad, A., Fakhri, B., Kahl, B. S., Churnetski, M. C., Cohen, J. B., Reddy, N. M., Modi, D., Ramchandren, R., Howlett, C., Leslie, L. A. & 20 others, Cytryn, S., Diefenbach, C. S., Faramand, R., Chavez, J. C., Olszewski, A. J., Liu, Y., Barta, S. K., Mukhija, D., Hill, B. T., Ma, H., Amengual, J. E., Nathan, S., Assouline, S. E., Orellana-Noia, V. M., Portell, C. A., Chandar, A., David, K. A., Giri, A., Hess, B. T. & Landsburg, D. J., Jan 15 2020, In : Cancer. 126, 2, p. 293-303 11 p.

Research output: Contribution to journalArticle

Outcomes of transformed follicular lymphoma in the modern era: A report from the National LymphoCare Study (NLCS)

Wagner-Johnston, N. D., Link, B. K., Byrtek, M., Dawson, K. L., Hainsworth, J., Flowers, C. R., Friedberg, J. W. & Bartlett, N. L., Aug 13 2015, In : Blood. 126, 7, p. 851-857 7 p.

Research output: Contribution to journalArticle

Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients

Schoch, L. K., Asiama, A., Zahurak, M., Shanbhag, S. P., Hurtt, J., Sawyer, K., Swinnen, L., Wagner-Johnston, N., Jones, R. J., Ambinder, R. F. & Gladstone, D., Dec 13 2017, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)

Rosenbaum, C. A., Jung, S. H., Pitcher, B., Bartlett, N. L., Smith, S. M., Hsi, E., Wagner-Johnston, N., Thomas, S. P., Leonard, J. P. & Cheson, B. D., Apr 2019, In : British journal of haematology. 185, 1, p. 53-64 12 p.

Research output: Contribution to journalArticle

Phase II intergroup trial of alisertib in relapsed and refractory peripheral T-cell lymphoma and transformed Mycosis fungoides: SWOG 1108

Barr, P. M., Li, H., Spier, C., Mahadevan, D., LeBlanc, M., Ul Haq, M., Huber, B. D., Flowers, C. R., Wagner-Johnston, N. D., Horwitz, S. M., Fisher, R. I., Cheson, B. D., Smith, S. M., Kahl, B. S., Bartlett, N. L. & Friedberg, J. W., Jul 20 2015, In : Journal of Clinical Oncology. 33, 21, p. 2399-2404 6 p.

Research output: Contribution to journalArticle

Phase II study of 9-aminocamptothecin in previously treated lymphomas: Results of Cancer and Leukemia Group B 9551

Bartlett, N. L., Johnson, J. L., Wagner-Johnston, N., Ratain, M. J. & Peterson, B. A., Apr 1 2009, In : Cancer Chemotherapy and Pharmacology. 63, 5, p. 793-798 6 p.

Research output: Contribution to journalArticle

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

Gopal, A. K., Kahl, B. S., Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., Flinn, I. W., Flowers, C. R., Martin, P., Viardot, A., Blum, K. A., Goy, A. H., Davies, A. J., Zinzani, P. L., Dreyling, M., Johnson, D., Miller, L. L., Holes, L., Li, D., Dansey, R. D. & 2 others, Godfrey, W. R. & Salles, G. A., Jan 1 2014, In : New England Journal of Medicine. 370, 11, p. 1008-1018 11 p.

Research output: Contribution to journalArticle

Poor outcomes for double-hit lymphoma patients treated with curative-intent second-line immunochemotherapy following failure of intensive front-line immunochemotherapy

Landsburg, D. J., Ayers, E. C., Bond, D. A., Maddocks, K. J., Karmali, R., Behdad, A., Curry, M., Wagner-Johnston, N. D., Modi, D., Ramchandren, R., Assouline, S. E., Faramand, R., Chavez, J. C., Torka, P., Mier Hicks, A., Medeiros, L. J. & Li, S., Apr 1 2020, In : British journal of haematology. 189, 2, p. 313-317 5 p.

Research output: Contribution to journalArticle

Postibrutinib outcomes in patients with mantle cell lymphoma

Martin, P., Maddocks, K., Leonard, J. P., Ruan, J., Goy, A., Wagner-Johnston, N., Rule, S., Advani, R., Iberri, D., Phillips, T., Spurgeon, S., Kozin, E., Noto, K., Chen, Z., Jurczak, W., Auer, R., Chmielowska, E., Stilgenbauer, S., Bloehdorn, J., Portell, C. & 7 others, Williams, M. E., Dreyling, M., Barr, P. M., Chen-Kiang, S., DiLiberto, M., Furman, R. R. & Blum, K. A., Mar 24 2016, In : Blood. 127, 12, p. 1559-1563 5 p.

Research output: Contribution to journalArticle

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

Carson, K. R., Newsome, S. D., Kim, E. J., Wagner-Johnston, N. D., Von Geldern, G., Moskowitz, C. H., Moskowitz, A. J., Rook, A. H., Jalan, P., Loren, A. W., Landsburg, D., Coyne, T., Tsai, D., Raisch, D. W., Norris, L. B., Bookstaver, P. B., Sartor, O. & Bennett, C. L., Aug 15 2014, In : Cancer. 120, 16, p. 2464-2471 8 p.

Research output: Contribution to journalArticle